首页 > 最新文献

中华心血管病杂志最新文献

英文 中文
[Familial hypercholesterolemia caused by compound heterozygous variants in the LDLR gene: a case report]. 【LDLR基因复合杂合变异引起的家族性高胆固醇血症1例报告】。
Q3 Medicine Pub Date : 2025-07-24 DOI: 10.3760/cma.j.cn112148-20250522-00389
K X Wang, Y L Ren, J R Zhang, X T Hou, X Y Li
{"title":"[Familial hypercholesterolemia caused by compound heterozygous variants in the LDLR gene: a case report].","authors":"K X Wang, Y L Ren, J R Zhang, X T Hou, X Y Li","doi":"10.3760/cma.j.cn112148-20250522-00389","DOIUrl":"https://doi.org/10.3760/cma.j.cn112148-20250522-00389","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"53 7","pages":"816-819"},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144709285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pericardial diseases: the missing piece in comprehensive prevention and treatment of cardiovascular diseases]. 【心包疾病:心血管疾病综合防治的缺失环节】。
Q3 Medicine Pub Date : 2025-07-24 DOI: 10.3760/cma.j.cn112148-20250314-00191
J X Song, S Sun, Y X Cui, H Chen
{"title":"[Pericardial diseases: the missing piece in comprehensive prevention and treatment of cardiovascular diseases].","authors":"J X Song, S Sun, Y X Cui, H Chen","doi":"10.3760/cma.j.cn112148-20250314-00191","DOIUrl":"https://doi.org/10.3760/cma.j.cn112148-20250314-00191","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"53 7","pages":"713-716"},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144709288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research on the pattern and influencing factors of cardiometabolic multimorbidity in China]. [中国心脏代谢多发病模式及影响因素研究]。
Q3 Medicine Pub Date : 2025-07-24 DOI: 10.3760/cma.j.cn112148-20240509-00247
Y F Wang, Z W Wang, C Y Zheng, X Wang, Y X Tian, X Cao, R H Feng

Objective: To investigate the prevalence, comorbidity patterns, and associated factors of cardiometabolic multimorbidity (CMM) in China. Methods: From 2012 to 2015, a total of 34 994 residents aged ≥35 years were enrolled using a stratified multistage random sampling method across 31 provinces, autonomous regions, and municipalities in China. Data were collected through questionnaires, covering demographic characteristics, behavioral and lifestyle factors, and self-reported history of cardiometabolic diseases. CMM was defined as the coexistence of two or more cardiometabolic diseases in the same individual. Association rule analysis using the Apriori algorithm from the arules package was employed to identify strong CMM patterns. Multivariable logistic regression was employed to explore factors associated with CMM. Results: The mean age of the participants was 55.6 years. Among them, 15 926 were male (45.51%). The prevalence of cardiometabolic multimorbidity (CMM) was 11.25% (3 937/34 994). A total of 35 distinct CMM combinations (each with a frequency ≥10) were identified. The most prevalent dyad, triad, and tetrad comorbidity patterns were hypertension+hyperlipidemia (1 036 cases), hypertension+hyperlipidemia+diabetes (352 cases), and hypertension+stroke+hyperlipidemia+diabetes (54 cases), respectively. Nine strong CMM patterns were identified using the Apriori association rule algorithm. Multivariable logistic regression analysis showed that older age (≥70 years: OR=17.39,95%CI 13.92-21.71,P<0.01), junior high school education (OR=1.31, 95%CI 1.17-1.48, P<0.01), senior high school or above education (OR=1.45, 95%CI 1.27-1.65, P<0.01), retirement (OR=3.09, 95%CI 2.76-3.46, P<0.01), unemployment or being laid-off (OR=1.16, 95%CI 1.06-1.28, P<0.01), a family history of cardiometabolic disease (OR=4.37, 95%CI 4.04-4.72, P<0.01), regular smoking (OR=1.38, 95%CI 1.24-1.53, P<0.05), and occasional smoking (OR=1.21, 95%CI 1.00-1.49, P<0.01) were significantly associated with an increased risk of CMM. Conclusion: The prevalence of cardiometabolic multimorbidity in China is relatively high, with the most common comorbidity patterns involving combinations of hypertension and hyperlipidemia, often accompanied by diabetes and stroke. Older age, retirement status, smoking, and a family history of cardiovascular disease are associated with an increased risk of both single and multiple cardiometabolic conditions. Greater attention should be paid to individuals with a single cardiometabolic disorder due to their elevated risk of developing multimorbidity.

目的:了解中国心脏代谢性多病(CMM)的患病率、合并症类型及相关因素。方法:2012 - 2015年,采用分层多阶段随机抽样方法,在中国31个省、自治区、直辖市共纳入34 994名年龄≥35岁的居民。通过问卷调查收集数据,包括人口统计学特征、行为和生活方式因素以及自我报告的心脏代谢疾病史。CMM被定义为同一个体同时存在两种或两种以上的心脏代谢疾病。利用规则包中的Apriori算法进行关联规则分析,识别强CMM模式。采用多变量logistic回归分析CMM的相关因素。结果:参与者的平均年龄为55.6岁。其中男性15 926人,占45.51%。心血管代谢多病(CMM)患病率为11.25%(3 937/34 994)。共鉴定出35种不同的CMM组合(每种频率≥10)。二、三、四合并症分别为高血压+高脂血症(1 036例)、高血压+高脂血症+糖尿病(352例)、高血压+脑卒中+高脂血症+糖尿病(54例)。利用Apriori关联规则算法识别出9种强CMM模式。多变量logistic回归分析显示,老年人(≥70岁):OR=17.39,95%CI 13.92-21.71,POR=1.31, 95%CI 1.17-1.48, POR=1.45, 95%CI 1.27-1.65, POR=3.09, 95%CI 2.76-3.46, POR=1.16, 95%CI 1.06-1.28, POR=4.37, 95%CI 4.04-4.72, POR=1.38, 95%CI 1.24-1.53, POR=1.21, 95%CI 1.00-1.49, p。在中国,心脏代谢多重疾病的患病率相对较高,最常见的合并症包括高血压和高脂血症的合并,通常伴有糖尿病和中风。年龄较大、退休状态、吸烟和心血管疾病家族史与单一和多种心脏代谢疾病的风险增加有关。应更多地关注个体与单一的心脏代谢紊乱,因为他们的高风险发展为多病。
{"title":"[Research on the pattern and influencing factors of cardiometabolic multimorbidity in China].","authors":"Y F Wang, Z W Wang, C Y Zheng, X Wang, Y X Tian, X Cao, R H Feng","doi":"10.3760/cma.j.cn112148-20240509-00247","DOIUrl":"https://doi.org/10.3760/cma.j.cn112148-20240509-00247","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the prevalence, comorbidity patterns, and associated factors of cardiometabolic multimorbidity (CMM) in China. <b>Methods:</b> From 2012 to 2015, a total of 34 994 residents aged ≥35 years were enrolled using a stratified multistage random sampling method across 31 provinces, autonomous regions, and municipalities in China. Data were collected through questionnaires, covering demographic characteristics, behavioral and lifestyle factors, and self-reported history of cardiometabolic diseases. CMM was defined as the coexistence of two or more cardiometabolic diseases in the same individual. Association rule analysis using the Apriori algorithm from the arules package was employed to identify strong CMM patterns. Multivariable logistic regression was employed to explore factors associated with CMM. <b>Results:</b> The mean age of the participants was 55.6 years. Among them, 15 926 were male (45.51%). The prevalence of cardiometabolic multimorbidity (CMM) was 11.25% (3 937/34 994). A total of 35 distinct CMM combinations (each with a frequency ≥10) were identified. The most prevalent dyad, triad, and tetrad comorbidity patterns were hypertension+hyperlipidemia (1 036 cases), hypertension+hyperlipidemia+diabetes (352 cases), and hypertension+stroke+hyperlipidemia+diabetes (54 cases), respectively. Nine strong CMM patterns were identified using the Apriori association rule algorithm. Multivariable logistic regression analysis showed that older age (≥70 years: <i>OR</i>=17.39,95%<i>CI</i> 13.92-21.71,<i>P</i><0.01), junior high school education (<i>OR</i>=1.31, 95%<i>CI</i> 1.17-1.48, <i>P</i><0.01), senior high school or above education (<i>OR</i>=1.45, 95%<i>CI</i> 1.27-1.65, <i>P</i><0.01), retirement (<i>OR</i>=3.09, 95%<i>CI</i> 2.76-3.46, <i>P</i><0.01), unemployment or being laid-off (<i>OR</i>=1.16, 95%<i>CI</i> 1.06-1.28, <i>P</i><0.01), a family history of cardiometabolic disease (<i>OR</i>=4.37, 95%<i>CI</i> 4.04-4.72, <i>P</i><0.01), regular smoking (<i>OR</i>=1.38, 95%<i>CI</i> 1.24-1.53, <i>P</i><0.05), and occasional smoking (<i>OR</i>=1.21, 95%<i>CI</i> 1.00-1.49, <i>P</i><0.01) were significantly associated with an increased risk of CMM. <b>Conclusion:</b> The prevalence of cardiometabolic multimorbidity in China is relatively high, with the most common comorbidity patterns involving combinations of hypertension and hyperlipidemia, often accompanied by diabetes and stroke. Older age, retirement status, smoking, and a family history of cardiovascular disease are associated with an increased risk of both single and multiple cardiometabolic conditions. Greater attention should be paid to individuals with a single cardiometabolic disorder due to their elevated risk of developing multimorbidity.</p>","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"53 7","pages":"792-798"},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144709291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The clinical application of fractional flow reserve and Doppler flow velocity derived from optical coherence tomography in coronary artery disease]. [光学相干断层扫描在冠状动脉疾病中的血流储备和多普勒血流速度的临床应用]。
Q3 Medicine Pub Date : 2025-07-24 DOI: 10.3760/cma.j.cn112148-20241128-00742
L Zhao, L B Li, B Liu, Z H Wang, J P Wang, B Li, Z W Xu

Objective: To explore the diagnostic value of fractional flow reserve (FFR) based on optical coherence tomography (OCT) for coronary functional ischemia, and to investigate the feasibility of synchronously obtaining Doppler blood flow velocity information with the help of OCT technology. Methods: This study was a single-center, prospective, self-controlled clinical study on coronary heart disease patients who underwent OCT and FFR assessment at Department of Cardiology, the Second Hospital of Jilin University from January 2024 to February 2025. Linear regression analysis was used to evaluate the correlation and consistency between OCT-FFR and FFR. With FFR≤0.80 as the gold standard for judging whether the target vessel was ischemic, the diagnostic performance of OCT-FFR was evaluated, and the diagnostic value of OCT-FFR for significant coronary artery ischemia was assessed using subject operating characteristic curves. Blood flow OCT data were analyzed by Doppler processing algorithm to obtain information on coronary blood flow velocity. Results: A total of 31 vessels from 28 patients were analyzed, the correlation coefficient r between OCT-FFR and FFR of the 31 vessels was 0.84 (P<0.001). With FFR as the gold standard to determine whether a coronary artery is ischemic, accuracy, sensitivity, specificity, positive predictive value, and negative predictive value for OCT-FFR was 93.55%, 75.00%, 100.00%, 1.00, 0.92. In clinical practice, Doppler OCT was used for the first time to obtain information on coronary blood flow velocity. Conclusion: OCT-FFR had an excellent correlation and consistency with FFR in judging whether there is coronary artery ischemia. The feasibility of the simultaneous acquisition of OCT-FFR and Doppler flow velocity information in coronary stenosis was preliminarily verified.

目的:探讨基于光学相干断层扫描(OCT)的血流储备分数(FFR)对冠状动脉功能性缺血的诊断价值,探讨利用OCT技术同步获取多普勒血流速度信息的可行性。方法:本研究是一项单中心、前瞻性、自我对照的临床研究,研究对象为2024年1月至2025年2月在吉林大学第二医院心内科接受OCT和FFR评估的冠心病患者。采用线性回归分析评价OCT-FFR与FFR的相关性和一致性。以FFR≤0.80为判断靶血管是否缺血的金标准,评价OCT-FFR的诊断性能,采用受试者工作特征曲线评价OCT-FFR对冠状动脉明显缺血的诊断价值。血流OCT数据采用多普勒处理算法进行分析,获取冠状动脉血流速度信息。结果:共分析28例患者31支血管,OCT-FFR与31支血管FFR的相关系数r为0.84 (p)。结论:OCT-FFR与FFR在判断是否存在冠状动脉缺血方面具有极好的相关性和一致性。初步验证了OCT-FFR和多普勒血流速度信息同时采集冠状动脉狭窄的可行性。
{"title":"[The clinical application of fractional flow reserve and Doppler flow velocity derived from optical coherence tomography in coronary artery disease].","authors":"L Zhao, L B Li, B Liu, Z H Wang, J P Wang, B Li, Z W Xu","doi":"10.3760/cma.j.cn112148-20241128-00742","DOIUrl":"https://doi.org/10.3760/cma.j.cn112148-20241128-00742","url":null,"abstract":"<p><p><b>Objective:</b> To explore the diagnostic value of fractional flow reserve (FFR) based on optical coherence tomography (OCT) for coronary functional ischemia, and to investigate the feasibility of synchronously obtaining Doppler blood flow velocity information with the help of OCT technology. <b>Methods:</b> This study was a single-center, prospective, self-controlled clinical study on coronary heart disease patients who underwent OCT and FFR assessment at Department of Cardiology, the Second Hospital of Jilin University from January 2024 to February 2025. Linear regression analysis was used to evaluate the correlation and consistency between OCT-FFR and FFR. With FFR≤0.80 as the gold standard for judging whether the target vessel was ischemic, the diagnostic performance of OCT-FFR was evaluated, and the diagnostic value of OCT-FFR for significant coronary artery ischemia was assessed using subject operating characteristic curves. Blood flow OCT data were analyzed by Doppler processing algorithm to obtain information on coronary blood flow velocity. <b>Results:</b> A total of 31 vessels from 28 patients were analyzed, the correlation coefficient <i>r</i> between OCT-FFR and FFR of the 31 vessels was 0.84 (<i>P</i><0.001). With FFR as the gold standard to determine whether a coronary artery is ischemic, accuracy, sensitivity, specificity, positive predictive value, and negative predictive value for OCT-FFR was 93.55%, 75.00%, 100.00%, 1.00, 0.92. In clinical practice, Doppler OCT was used for the first time to obtain information on coronary blood flow velocity. <b>Conclusion:</b> OCT-FFR had an excellent correlation and consistency with FFR in judging whether there is coronary artery ischemia. The feasibility of the simultaneous acquisition of OCT-FFR and Doppler flow velocity information in coronary stenosis was preliminarily verified.</p>","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"53 7","pages":"799-805"},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144709292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The predictive value of cardiac MRI for the first episode of malignant ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy]. 【心脏MRI对致心律失常右室心肌病首发恶性室性心律失常的预测价值】。
Q3 Medicine Pub Date : 2025-07-24 DOI: 10.3760/cma.j.cn112148-20250117-00055
Z X Dong, Y Y Song, X Ma, J X Wang, S J Yang, Y Tang, P Y Zhou, K Yang, X Y Chen, X X Zhao, S H Zhao

Objective: To explore the value of cardiac magnetic resonance imaging (CMR) derived left ventricular late gadolinium enhancement (LV LGE) for the primary prevention of malignant ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy (ARVC) patients. Methods: This was a single-center retrospective study. Consecutive ARVC patients who underwent CMR at Fuwai Hospital between January 2016 and September 2020, with no history of malignant ventricular arrhythmias at diagnosis, were enrolled. Clinical data and CMR characteristics were collected. The primary endpoint was defined as new-onset malignant ventricular arrhythmias related events, including sustained ventricular tachycardia, ventricular fibrillation/flutter, sudden cardiac death, cardiac arrest, and appropriate implantable cardioverter-defibrillator discharge. Follow-up via telephone interviews and medical records was conducted to confirm endpoint occurrences, and patients were categorized into event-free and event groups based on endpoint status. Univariable and multivariable Cox regression analysis were performed to identify independent risk factors for malignant ventricular arrhythmias in ARVC patients. Subgroup analyses were conducted based on the ARVC 5-year risk score (cutoff: 25%) and the median value of LV LGE percentage (cutoff: 13%). Kaplan-Meier curves were plotted, and log-rank tests were used to compare the difference in the incidence of primary endpoint events between subgroups. Receiver operating characteristic curves and likelihood ratio test were used to evaluate the incremental prognostic value of LV LGE percentage beyond the ARVC 5-year risk score. Results: A total of 172 ARVC patients were enrolled, aged (39.0±16.6) years, including 73 females (42.4%). During a follow-up of 53.1 (25.4, 76.9) months, 51 patients (29.7%) experienced malignant ventricular arrhythmias related events, including 3 cases of sudden cardiac death, 1 cardiac arrest, 33 sustained ventricular tachycardia and 14 appropriate implantable cardioverter-defibrillator discharges. Multivariable Cox regression analysis indicated that the ARVC 5-year risk score (HR=1.028, 95%CI 1.015-1.041, P<0.001) and LV LGE percentage (HR=1.059, 95%CI 1.032-1.087, P<0.001) were independent risk factors of the primary endpoint events. Kaplan-Meier analysis using composite stratification (ARVC 5-year risk score cutoff: 25%; LV LGE percentage cutoff: 13%) demonstrated that patients with both high risk scores (≥25%) and extensive LV LGE (≥13%) had the highest risk of primary endpoint events. Notably, among patients with ARVC 5-year risk scores <25%, those with LV LGE≥13% had a higher incidence of primary endpoint events than those without (log-rank P=0.037). The composite prediction model combining the 5-year risk score and left ventricular LGE percentage demonstrated significantly improved predictive performance (area under the curve (<

目的:探讨心脏磁共振成像(CMR)衍生左室晚期钆增强(LV LGE)对致心律失常右室心肌病(ARVC)患者恶性室性心律失常的一级预防价值。方法:本研究为单中心回顾性研究。纳入2016年1月至2020年9月在阜外医院连续行CMR的ARVC患者,诊断时无恶性室性心律失常史。收集临床资料和CMR特征。主要终点定义为新发恶性室性心律失常相关事件,包括持续性室性心动过速、室性颤动/扑动、心源性猝死、心脏骤停和适当的植入式心律转复除颤器出院。通过电话访谈和医疗记录进行随访以确认终点的发生,并根据终点状态将患者分为无事件组和事件组。采用单变量和多变量Cox回归分析,确定ARVC患者恶性室性心律失常的独立危险因素。根据ARVC 5年风险评分(截止值:25%)和LV LGE百分比中位数(截止值:13%)进行亚组分析。绘制Kaplan-Meier曲线,并采用log-rank检验比较亚组间主要终点事件发生率的差异。采用受试者工作特征曲线和似然比检验评价LV LGE百分比超出ARVC 5年风险评分的增量预后价值。结果:共纳入ARVC患者172例,年龄(39.0±16.6)岁,其中女性73例(42.4%)。在53.1(25.4,76.9)个月的随访中,51例(29.7%)发生恶性室性心律失常相关事件,其中心源性猝死3例,心搏骤停1例,持续性室性心动过速33例,适当的植入式心律转复除颤器出院14例。多变量Cox回归分析显示,ARVC 5年风险评分(HR=1.028, 95%CI 1.015 ~ 1.041, PHR=1.059, 95%CI 1.032 ~ 1.087, PP=0.037)。结合5年风险评分和左室LGE百分比的复合预测模型预测效果显著提高(曲线下面积(area under The curve, AUC)=0.82, 95%CI 0.75 ~ 0.90;似然比检验所有pac =0.71, 95%CI 0.63-0.82, P=0.01;单独5年风险评分:AUC=0.71, 95%CI 0.62-0.81, P=0.02)。结论:左室LGE百分比独立预测ARVC患者新发恶性室性心律失常,并在现有ARVC 5年风险评分的基础上提供增量预后价值。
{"title":"[The predictive value of cardiac MRI for the first episode of malignant ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy].","authors":"Z X Dong, Y Y Song, X Ma, J X Wang, S J Yang, Y Tang, P Y Zhou, K Yang, X Y Chen, X X Zhao, S H Zhao","doi":"10.3760/cma.j.cn112148-20250117-00055","DOIUrl":"https://doi.org/10.3760/cma.j.cn112148-20250117-00055","url":null,"abstract":"<p><p><b>Objective:</b> To explore the value of cardiac magnetic resonance imaging (CMR) derived left ventricular late gadolinium enhancement (LV LGE) for the primary prevention of malignant ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy (ARVC) patients. <b>Methods:</b> This was a single-center retrospective study. Consecutive ARVC patients who underwent CMR at Fuwai Hospital between January 2016 and September 2020, with no history of malignant ventricular arrhythmias at diagnosis, were enrolled. Clinical data and CMR characteristics were collected. The primary endpoint was defined as new-onset malignant ventricular arrhythmias related events, including sustained ventricular tachycardia, ventricular fibrillation/flutter, sudden cardiac death, cardiac arrest, and appropriate implantable cardioverter-defibrillator discharge. Follow-up via telephone interviews and medical records was conducted to confirm endpoint occurrences, and patients were categorized into event-free and event groups based on endpoint status. Univariable and multivariable Cox regression analysis were performed to identify independent risk factors for malignant ventricular arrhythmias in ARVC patients. Subgroup analyses were conducted based on the ARVC 5-year risk score (cutoff: 25%) and the median value of LV LGE percentage (cutoff: 13%). Kaplan-Meier curves were plotted, and log-rank tests were used to compare the difference in the incidence of primary endpoint events between subgroups. Receiver operating characteristic curves and likelihood ratio test were used to evaluate the incremental prognostic value of LV LGE percentage beyond the ARVC 5-year risk score. <b>Results:</b> A total of 172 ARVC patients were enrolled, aged (39.0±16.6) years, including 73 females (42.4%). During a follow-up of 53.1 (25.4, 76.9) months, 51 patients (29.7%) experienced malignant ventricular arrhythmias related events, including 3 cases of sudden cardiac death, 1 cardiac arrest, 33 sustained ventricular tachycardia and 14 appropriate implantable cardioverter-defibrillator discharges. Multivariable Cox regression analysis indicated that the ARVC 5-year risk score (<i>HR</i>=1.028, 95%<i>CI</i> 1.015-1.041, <i>P</i><0.001) and LV LGE percentage (<i>HR</i>=1.059, 95%<i>CI</i> 1.032-1.087, <i>P</i><0.001) were independent risk factors of the primary endpoint events. Kaplan-Meier analysis using composite stratification (ARVC 5-year risk score cutoff: 25%; LV LGE percentage cutoff: 13%) demonstrated that patients with both high risk scores (≥25%) and extensive LV LGE (≥13%) had the highest risk of primary endpoint events. Notably, among patients with ARVC 5-year risk scores <25%, those with LV LGE≥13% had a higher incidence of primary endpoint events than those without (log-rank <i>P</i>=0.037). The composite prediction model combining the 5-year risk score and left ventricular LGE percentage demonstrated significantly improved predictive performance (area under the curve (<","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"53 7","pages":"784-791"},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144709293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical characteristics and treatment outcomes in patients with recurrent pericarditis]. 复发性心包炎患者的临床特点及治疗结果。
Q3 Medicine Pub Date : 2025-07-24 DOI: 10.3760/cma.j.cn112148-20250210-00096
S Sun, M Zhao, Y X Cui, J Song, J T Chen, H Chen, J X Song

Objective: To summarize and analyze the clinical characteristics and treatment outcomes of patients with recurrent pericarditis. Methods: This observational study consecutively recruited patients with recurrent pericarditis who were hospitalized at Peking University People's Hospital between January 2017 and February 2024. Clinical characteristics and treatment outcomes were collected and summarized during follow-up. Results: A total of 8 recurrent pericarditis patients including 3 males were included, with an age of 34.0 (22.0, 39.5) years. In terms of clinical features, all patients presented with acute-onset severe chest pain, accompanied by fever in 7 and an audible pericardial friction rub in 2 patients. Electrocardiogram showed no diffuse ST-segment elevation or PR-segment depression in any patient. Echocardiography revealed pericardial effusion in all cases, with extensive fibrinous exudate and transient pericardial thickening observed in 6 patients. CT identified concurrent pleural and/or peritoneal effusions in 6 patients. All patients exhibited marked elevations in C-reactive protein, erythrocyte sedimentation rate and D-dimer levels. Whole-exome sequencing identified MEFV gene mutations associated with familial Mediterranean fever in 3 cases. Two patients developed cardiac tamponade requiring pericardiocentesis, which revealed hemorrhagic effusion. In the aspect of treatment outcomes, the time from recurrence to first confirmed diagnosis of recurrent pericarditis of this cohort was 14.5 (13.3, 19.5) d. Upon diagnosis, all patients promptly received standard anti-inflammatory therapy with ibuprofen and colchicine, achieving rapid relief. However, during a follow-up of 12.0 (6.0, 25.3) months, 3 patients experienced recurrence, and 2 developed transient constrictive pericarditis. Conclusion: Patients with recurrent pericarditis typically exhibit characteristic clinical presentations, laboratory abnormalities, imaging findings and potential genetic associations. Although standard anti-inflammatory therapy demonstrates favorable short-term efficacy, long-term management remains challenging due to the risks of recurrence and progression to constrictive pericarditis.

目的:总结分析复发性心包炎患者的临床特点及治疗效果。方法:本观察性研究连续招募2017年1月至2024年2月在北京大学人民医院住院的复发性心包炎患者。随访期间收集临床特征及治疗结果进行总结。结果:本组共8例复发性心包炎患者,其中男性3例,年龄34.0(22.0,39.5)岁。临床表现均表现为急性剧烈胸痛,7例伴发热,2例伴心包摩擦声。心电图未见弥漫性st段抬高或pr段降低。超声心动图显示所有病例均有心包积液,其中6例有广泛的纤维性渗出和短暂性心包增厚。CT发现6例患者并发胸膜和/或腹膜积液。所有患者均表现出c反应蛋白、红细胞沉降率和d -二聚体水平的显著升高。全外显子组测序发现3例MEFV基因突变与家族性地中海热相关。两名患者出现心包填塞,需要心包穿刺,结果显示出出血积液。在治疗结果方面,从复发到首次确诊复发性心包炎的时间为14.5 (13.3,19.5)d。确诊后,所有患者均及时接受布洛芬和秋水仙碱的标准抗炎治疗,快速缓解。然而,在12.0(6.0,25.3)个月的随访中,3例患者复发,2例发生短暂缩窄性心包炎。结论:复发性心包炎患者通常表现出特征性的临床表现、实验室异常、影像学表现和潜在的遗传关联。虽然标准的抗炎治疗显示出良好的短期疗效,但由于复发和进展为缩窄性心包炎的风险,长期管理仍然具有挑战性。
{"title":"[Clinical characteristics and treatment outcomes in patients with recurrent pericarditis].","authors":"S Sun, M Zhao, Y X Cui, J Song, J T Chen, H Chen, J X Song","doi":"10.3760/cma.j.cn112148-20250210-00096","DOIUrl":"https://doi.org/10.3760/cma.j.cn112148-20250210-00096","url":null,"abstract":"<p><p><b>Objective:</b> To summarize and analyze the clinical characteristics and treatment outcomes of patients with recurrent pericarditis. <b>Methods:</b> This observational study consecutively recruited patients with recurrent pericarditis who were hospitalized at Peking University People's Hospital between January 2017 and February 2024. Clinical characteristics and treatment outcomes were collected and summarized during follow-up. <b>Results:</b> A total of 8 recurrent pericarditis patients including 3 males were included, with an age of 34.0 (22.0, 39.5) years. In terms of clinical features, all patients presented with acute-onset severe chest pain, accompanied by fever in 7 and an audible pericardial friction rub in 2 patients. Electrocardiogram showed no diffuse ST-segment elevation or PR-segment depression in any patient. Echocardiography revealed pericardial effusion in all cases, with extensive fibrinous exudate and transient pericardial thickening observed in 6 patients. CT identified concurrent pleural and/or peritoneal effusions in 6 patients. All patients exhibited marked elevations in C-reactive protein, erythrocyte sedimentation rate and D-dimer levels. Whole-exome sequencing identified MEFV gene mutations associated with familial Mediterranean fever in 3 cases. Two patients developed cardiac tamponade requiring pericardiocentesis, which revealed hemorrhagic effusion. In the aspect of treatment outcomes, the time from recurrence to first confirmed diagnosis of recurrent pericarditis of this cohort was 14.5 (13.3, 19.5) d. Upon diagnosis, all patients promptly received standard anti-inflammatory therapy with ibuprofen and colchicine, achieving rapid relief. However, during a follow-up of 12.0 (6.0, 25.3) months, 3 patients experienced recurrence, and 2 developed transient constrictive pericarditis. <b>Conclusion:</b> Patients with recurrent pericarditis typically exhibit characteristic clinical presentations, laboratory abnormalities, imaging findings and potential genetic associations. Although standard anti-inflammatory therapy demonstrates favorable short-term efficacy, long-term management remains challenging due to the risks of recurrence and progression to constrictive pericarditis.</p>","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"53 7","pages":"769-775"},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144709282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Predictive value of echocardiography for acute kidney injury in congestive heart failure]. 超声心动图对充血性心力衰竭急性肾损伤的预测价值。
Q3 Medicine Pub Date : 2025-07-24 DOI: 10.3760/cma.j.cn112148-20250521-00383
S Y Wei, J Wang, R R Hao, Y H Zhang
{"title":"[Predictive value of echocardiography for acute kidney injury in congestive heart failure].","authors":"S Y Wei, J Wang, R R Hao, Y H Zhang","doi":"10.3760/cma.j.cn112148-20250521-00383","DOIUrl":"https://doi.org/10.3760/cma.j.cn112148-20250521-00383","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"53 7","pages":"844-848"},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144709289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Expert consensus on glycemic variability management in patients with cardiovascular diseases]. [心血管疾病患者血糖变异性管理的专家共识]。
Q3 Medicine Pub Date : 2025-07-24 DOI: 10.3760/cma.j.cn112148-20241022-00635
{"title":"[Expert consensus on glycemic variability management in patients with cardiovascular diseases].","authors":"","doi":"10.3760/cma.j.cn112148-20241022-00635","DOIUrl":"10.3760/cma.j.cn112148-20241022-00635","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"53 7","pages":"757-768"},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144709284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Advances in sarcomeric protein-coding genes underllying hypertrophic cardiomyopathy]. [肥厚性心肌病的肌瘤蛋白编码基因研究进展]。
Q3 Medicine Pub Date : 2025-07-24 DOI: 10.3760/cma.j.cn112148-20250513-00354
Y Wang, S J Liu, L Yang, Y He
{"title":"[Advances in sarcomeric protein-coding genes underllying hypertrophic cardiomyopathy].","authors":"Y Wang, S J Liu, L Yang, Y He","doi":"10.3760/cma.j.cn112148-20250513-00354","DOIUrl":"https://doi.org/10.3760/cma.j.cn112148-20250513-00354","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"53 7","pages":"820-825"},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144709280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research advances in valve durability and lifetime management strategies for patients with aortic stenosis after TAVR]. [TAVR术后主动脉瓣狭窄患者瓣膜耐久性及终生管理策略研究进展]。
Q3 Medicine Pub Date : 2025-07-24 DOI: 10.3760/cma.j.cn112148-20250520-00378
Y X Fang, W Z Pan, D X Zhou
{"title":"[Research advances in valve durability and lifetime management strategies for patients with aortic stenosis after TAVR].","authors":"Y X Fang, W Z Pan, D X Zhou","doi":"10.3760/cma.j.cn112148-20250520-00378","DOIUrl":"https://doi.org/10.3760/cma.j.cn112148-20250520-00378","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"53 7","pages":"825-830"},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144709290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华心血管病杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1